cprx stock price target

Long term Catalyst Pharmaceuticals stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Jul. According to 5 Wall Street analyst s that have issued a 1 year CPRX price target the average CPRX price target is 1160 with the highest CPRX stock price forecast at 1500 and the lowest CPRX stock price forecast at 900.

Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental

CPRX analyst stock forecast price target and recommendation trends with in.

. Find the latest Catalyst Pharmaceuticals Inc. The average twelve-month price prediction for Catalyst Pharmaceuticals is 1092 with a high price target of 1200 and a low price target of 875. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

The Best Blue-Chip Stocks. Average Target Price. During the day the stock fluctuated 383 from a day low at 647 to a day high of 672.

Based on analysts offering 12 month price targets for CPRX in the last 3 months. The latest price target for. The more significant the discrepancy.

While empirical research shows that this sought-after metric is. The analyst firm set a. While empirical research shows that this sought-after metric is hardly effective an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

On average Wall Street analysts predict that CATALYST PHARMACEUTICALS s share price could reach 1160 by May 12 2023. 4 equities research analysts have issued 12-month price targets for Catalyst Pharmaceuticals stock. According to 11 analysts the average rating for CPRX stock is Buy The 12-month stock price forecast is 1183 which is an increase of 7816 from the latest price.

Find the latest Catalyst Pharmaceuticals Inc CPRX stock price forecast 12-month price target predictions and analyst recommendations. Stock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low estimate of 900. Do note that if the stock price.

US Markets Close In. CPRX Stock Trend. The average price target is 1200 with a high forecast of 1200 and a low forecast of 1200.

According to the issued ratings of 4 analysts in the last year the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The consensus price target hints at a 333 upside potential for Catalyst CPRX. This suggests a possible upside of 538 from the stocks current price.

Ad Our Strong Buys Double the SP. Their CPRX stock forecasts range from 875 to 1200. CPRXs average price target has moved up 265 over the prior 29 weeks.

The consensus price target hints at a 333 upside potential for Catalyst CPRX. 1y Target Est 1160 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate. Catalyst Pharmaceuticals Inc.

The median estimate represents. 8576 Upside Based on 1 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. Catalyst Pharms current and average target prices are 651 and 980 respectively.

Is 723 for 2023 Jun. The Catalyst Pharmaceuticals stock price gained 183 on the last trading day Thursday 23rd Jun 2022 rising from 657 to 669. On February 8 2022.

Zacks proprietary data indicates that Catalyst Pharmaceuticals Inc. Based On Fundamental Analysis. Is 207 for 2027 Jun.

The current price of Catalyst Pharm is the price at which Catalyst Pharm is currently trading. Over the past 50 weeks CPRXs average upside potential has been 466. Is 140 for 2031 Jun.

It will be interesting to see if todays upgrade is enough to propel. On average they predict Catalyst Pharmaceuticals share price to reach 1092 in the next year. Is 158 and for 2032 Jun.

The 2 analysts offering price forecasts for Catalyst Pharmaceutical Partners have a median target of 950 with a high estimate of 1200 and a low estimate of 700. Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

Analyst Price Target on CPRX. CPRX was reported by HC Wainwright Co. The average price target represents a 8576 change from the last price of 646.

Todays 52-Week Highs. CPRX stock forecast and price target. Is 650 for 2026 Jun.

On the other hand Catalyst Pharms target price is what analysts think the stock is worth or could sell for in the future. Catalyst Pharmaceuticals has also found favour with investors with the stock up a worthy 14 to US654 over the past week. And has now gained 5 days in a rowIt will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.

Given the current short-term trend the stock is expected to fall -2325 during the next 3 months and with a 90 probability hold a price between 457 and 533 at the end of this 3-month period.

Laser Frenectomies And Tongue Ties Everyone Has A Muscle Attachment Frenum That Connects Their Lips To Their Gums However Smile Dental Dental Tourism Dental